Intrauterine Reprogramming of the Polycystic Ovary Syndrome: Evidence from a Pilot Study of Cord Blood Global Methylation Analysis

Polycystic ovary syndrome (PCOS) affects 5–15% of women. PCOS is a heterogeneous disorder displaying endocrine, metabolic, and reproductive dysfunction and cardiovascular risk manifestations. Evidence of heritability exists, but only a portion of the genetic transmission has been identified by genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambertini, Luca, Saul, Shira Rebecca, Copperman, Alan B., Hammerstad, Sara Salehi, Yi, Zhengzi, Zhang, Weijia, Tomer, Yaron, Kase, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741701/
https://www.ncbi.nlm.nih.gov/pubmed/29326659
http://dx.doi.org/10.3389/fendo.2017.00352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741701/
https://www.ncbi.nlm.nih.gov/pubmed/29326659
http://dx.doi.org/10.3389/fendo.2017.00352

Ejemplares similares